The goal of this clinical trial is to learn if pulsed electromagnetic field (PEMF) combined with home exercise improves healing and function in adults with meniscus tears. The main questions it aims to answer are:
1. Does PEMF therapy help heal meniscus tears, as seen on MRI scans?
2. Does PEMF therapy subjectively reduce knee pain, improve movement, and enhance quality of life?
3. Does PEMF therapy objectively help patients perform daily activities more easily?
Researchers will compare PEMF therapy against a sham (inactive) treatment to determine if it provides additional benefits.
Participants will:
* Be assigned randomly to either the PEMF group (active treatment) or the sham PEMF group (inactive, but identical in appearance)
* Receive either real PEMF therapy or sham treatment twice a week for 8 weeks (each session lasts 10 minutes).
* Follow a standard home exercise program to strengthen their knees.
* Have their knee function, pain levels, and healing progress checked through MRI scans, questionnaires, imaging and physical tests.
* Return for 3 follow-up visits after the 8-week treatment period.
Eligibility
Sex
ALL
Min age
18 Years
Max age
60 Years
Healthy volunteers
No
Inclusion Criteria:
* Male and female patients aged 18-60
* Clinical history, signs, and symptoms indicative of a meniscal tear
* MRI confirmation of a non-displaced, and unilateral meniscal tear
* Meniscal tears located within red-white and white-white zones
* Willingness to adhere to a 8-week regimen of PEMF and exercise therapy
* Ability to provide written informed consent
Exclusion Criteria:
* Congenital discoid meniscus confirmed by MRI
* Complex, oblique, flap, or displaced bucket handle tears confirmed by MRI
* Meniscal root tears confirmed by MRI
* Evidence of partial healing on baseline MRI
* Presence of mechanical symptoms (e.g., locking or catching)
* Acute onset exacerbation of knee symptoms (e.g., severe pain or swelling)
* Surgical intervention during the therapy session
* Knee axis deformities that necessitate surgical correction
* Prior surgery or fracture in the affected limb within the past 12 months
* Severe radiographic knee OA (Kellgren-Lawrence scale ≥2)
* Implanted electronic medical devices (e.g., pacemakers or cochlear implants) • Current pregnancy or intention to become pregnant during the study period
Primary outcome measure(s)
Between-group difference in mean change of intrameniscal fluid-equivalent signal area at 6 months post-intervention, as assessed by MRI. — Baseline to 6 months post intervention A musculoskeletal radiologist, blinded to the participants' group assignments and clinical details, will perform these assessments using fat- suppressed T2-weighted imaging. The primary imaging endpoint will be the between-group difference in the mean change of the intrameniscal fluid-equivalent signal area (mm2) from baseline to 6 months. The fluid-equivalent signal area will be delineated and quantified using standardized region-of-interest (ROI) methods on consecutive slices encompassing the original tear site.
Trial sites (1)
Facility
City
Region
Status
Room 124007, 10/F, Lui Chi Woo Clinical Sciences Building, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China
Hong Kong
Hong Kong
More Chinese University of Hong Kong trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.